Product Information

ULORIC 40 MG TABLET is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $10.5537 per EA under NDC 64764091830. Its NADAC has been published 657 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the febuxostat market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ULORIC 40 MG TABLET

febuxostat
$10.5537per EA
High Outlier

Strength

40 mg/1

NDC

64764091830

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

FEBUXOSTAT

Approval Type

New Drug (NDA)

FDA Application

NDA021856

On Market Since

2/13/2009

Pharmacological Classes

Xanthine Oxidase Inhibitor
Xanthine Oxidase Inhibitors

Price Statistics

The NADAC for ULORIC 40 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 60.1%. The table below summarizes its recorded NADAC range and movement.

Current price$10.5537 per EA
All-time high$10.6068 (Jun 16, 2021)
All-time low$6.5931 (Nov 28, 2013)
52-week high$10.5915
52-week low$10.5449
Median price$10.5244
Average price$9.8418
Largest weekly change+9.9% (Apr 15, 2015)
Weeks tracked657
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+0.1%

3M

-0.0%

6M

-0.2%

1Y

-0.1%

3Y

-0.5%

5Y

+0.3%

All

+60.1%

Generic Alternatives

The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ULORIC 40 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ULORIC 40 MG TABLET, manufactured by Takeda Pharmaceuticals America, Inc., is $10.5537 per EA (NDC 64764091830), effective Jun 24, 2026.

How has the price of ULORIC 40 MG TABLET changed over time?

Over the history we have for it, the NADAC for ULORIC 40 MG TABLET has risen 60.1%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ULORIC 40 MG TABLET?

Since Nov 28, 2013, the NADAC for ULORIC 40 MG TABLET has ranged from a low of $6.5931 (Nov 28, 2013) to a high of $10.6068 (Jun 16, 2021), with a median of $10.5244 per EA.

Are there cheaper alternatives to ULORIC 40 MG TABLET?

Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, FEBUXOSTAT 40 MG TABLET, is $0.2128 per EA — about 98% below ULORIC 40 MG TABLET.

Who manufactures ULORIC 40 MG TABLET?

ULORIC 40 MG TABLET (NDC 64764091830) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.

Related Drugs

Same classification

No related drugs found.